Log in

NASDAQ:SWAV - Shockwave Medical Stock Price, Forecast & News

$27.25
-5.93 (-17.87 %)
(As of 04/2/2020 06:00 AM ET)
Today's Range
$26.33
Now: $27.25
$30.32
50-Day Range
$23.16
MA: $36.80
$47.74
52-Week Range
$22.01
Now: $27.25
$68.39
Volume1.05 million shs
Average Volume509,870 shs
Market Capitalization$865.62 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
ShockWave Medical, Inc., a medical device company, develops and commercializes intravascular lithotripsy technology to treat calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease; C2 catheters for treating coronary artery disease; and S4 catheters or treating below-the-knee peripheral artery disease. It serves interventional cardiologists, vascular surgeons, and interventional radiologists through sales representatives and sales managers, and distributors. The company was incorporated in 2009 and is headquartered in Santa Clara, California.
Read More

Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:SWAV
CUSIPN/A
CIKN/A
Phone510-279-4262

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$42.93 million
Book Value$6.81 per share

Profitability

Net Income$-51,110,000.00
Net Margins-119.06%

Miscellaneous

Employees162
Market Cap$865.62 million
Next Earnings Date5/13/2020 (Estimated)
OptionableNot Optionable

Receive SWAV News and Ratings via Email

Sign-up to receive the latest news and ratings for SWAV and its competitors with MarketBeat's FREE daily newsletter.


Shockwave Medical (NASDAQ:SWAV) Frequently Asked Questions

How has Shockwave Medical's stock been impacted by COVID-19 (Coronavirus)?

Shockwave Medical's stock was trading at $34.44 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, SWAV stock has decreased by 20.9% and is now trading at $27.25. View which stocks have been mosted impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Shockwave Medical?

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Shockwave Medical in the last year. There are currently 1 sell rating, 1 hold rating and 5 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Shockwave Medical.

When is Shockwave Medical's next earnings date?

Shockwave Medical is scheduled to release its next quarterly earnings announcement on Wednesday, May 13th 2020. View our earnings forecast for Shockwave Medical.

How were Shockwave Medical's earnings last quarter?

Shockwave Medical Inc (NASDAQ:SWAV) released its quarterly earnings results on Thursday, February, 13th. The company reported ($0.49) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.51) by $0.02. The company earned $14.31 million during the quarter, compared to analysts' expectations of $13.34 million. Shockwave Medical had a negative net margin of 119.06% and a negative return on equity of 37.20%. View Shockwave Medical's earnings history.

What guidance has Shockwave Medical issued on next quarter's earnings?

Shockwave Medical issued an update on its FY 2020 After-Hours earnings guidance on Thursday, February, 13th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $74-77 million, compared to the consensus revenue estimate of $75.34 million.

What price target have analysts set for SWAV?

7 equities research analysts have issued 1 year price objectives for Shockwave Medical's stock. Their forecasts range from $23.00 to $54.00. On average, they anticipate Shockwave Medical's stock price to reach $44.43 in the next year. This suggests a possible upside of 63.0% from the stock's current price. View analysts' price targets for Shockwave Medical.

Has Shockwave Medical been receiving favorable news coverage?

Headlines about SWAV stock have been trending very negative on Thursday, according to InfoTrie Sentiment. InfoTrie ranks the sentiment of media coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Shockwave Medical earned a news sentiment score of -3.3 on InfoTrie's scale. They also gave press coverage about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an effect on the company's share price in the immediate future. View the latest news aboutShockwave Medical.

Are investors shorting Shockwave Medical?

Shockwave Medical saw a increase in short interest in March. As of March 13th, there was short interest totaling 3,945,400 shares, an increase of 5.5% from the February 27th total of 3,740,000 shares. Based on an average trading volume of 560,600 shares, the short-interest ratio is currently 7.0 days. Approximately 20.2% of the company's stock are short sold. View Shockwave Medical's Current Options Chain.

Who are some of Shockwave Medical's key competitors?

What other stocks do shareholders of Shockwave Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Shockwave Medical investors own include NVIDIA (NVDA), Alibaba Group (BABA), salesforce.com (CRM), Paypal (PYPL), Walt Disney (DIS), Twilio (TWLO), Roku (ROKU), Trade Desk (TTD), Veeva Systems (VEEV) and Home Depot (HD).

Who are Shockwave Medical's key executives?

Shockwave Medical's management team includes the following people:
  • Mr. Douglas E. Godshall, CEO, Pres & Director (Age 54)
  • Mr. Daniel Puckett, CFO & Sec. (Age 55)
  • Mr. Isaac Zacharias, Chief Commercial Officer (Age 44)
  • Mr. Daniel Hawkins, Founder and Sr. Advisor (Age 52)
  • Mr. John M. Adams, Co-Founder and Technical Advisor (Age 72)

When did Shockwave Medical IPO?

(SWAV) raised $75 million in an IPO on Thursday, March 7th 2019. The company issued 5,000,000 shares at $14.00-$16.00 per share. Morgan Stanley and BofA Merrill Lynch served as the underwriters for the IPO and Wells Fargo Securities and Canaccord Genuity were co-managers.

What is Shockwave Medical's stock symbol?

Shockwave Medical trades on the NASDAQ under the ticker symbol "SWAV."

How do I buy shares of Shockwave Medical?

Shares of SWAV can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Shockwave Medical's stock price today?

One share of SWAV stock can currently be purchased for approximately $27.25.

How big of a company is Shockwave Medical?

Shockwave Medical has a market capitalization of $865.62 million and generates $42.93 million in revenue each year. The company earns $-51,110,000.00 in net income (profit) each year or ($2.14) on an earnings per share basis. Shockwave Medical employs 162 workers across the globe. View additional information about Shockwave Medical.

What is Shockwave Medical's official website?

The official website for Shockwave Medical is http://www.shockwavemedical.com/.

How can I contact Shockwave Medical?

Shockwave Medical's mailing address is 5403 Betsy Ross Drive, Santa Clara CA, 95054. The company can be reached via phone at 510-279-4262 or via email at [email protected]


MarketBeat Community Rating for Shockwave Medical (NASDAQ SWAV)

Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  69 (Vote Outperform)
Underperform Votes:  80 (Vote Underperform)
Total Votes:  149
MarketBeat's community ratings are surveys of what our community members think about Shockwave Medical and other stocks. Vote "Outperform" if you believe SWAV will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SWAV will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 4/2/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel